ArticleFrontiers in immunology2023
A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer.
Qianhe Ren et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
51 papers cite it
this paperpooled itcites it